MATEON AND GMP COMPLETED RESEARCH AND SERVICE AGREEMENT
22 juin 2020 08h00 HE
|
Mateon Therapeutics, Inc.
- Mateon and GMP to proceed to clinical development of OT-101 and Artemisin and other antisense drug candidates against COVID-19 AGOURA HILLS, Calif., June 22, 2020 (GLOBE NEWSWIRE) --...